China Medical System won “Golden Wing Award — the Company with the most substantial growth potential”

Company News

Host by the Securities Times, “clear the fog and put the insight into the future-2018 ‘Golden Wing Award’ ceremony for Hong Kong stock-connect companies” was held at the Four Seasons Hotel in Shenzhen on October 19, 2018. China Medical System Holdings Ltd. (“CMS”) won the award of “Hong Kong stock-connect company with the most substantial growth potential” for its steady performance in recent years.

The “2018 Golden Wing Award for the most valuable Hong Kong stock-connect companies” is the first award event hosted by the Securities Times and guided by the Hong Kong Stock Exchange and the Shenzhen Stock Exchange. It aims at commending high quality Hong Kong stock-connect companies in order to enhance their brand image as well as promote deeper cooperation and communication between the A-shares and HK-shares capital markets. The awards were comprehensively evaluated by an expert committee and online votes.

The award reflects the high recognition on CMS’s past business performance and high expectation on its growth potential within capital markets. The group will unceasingly conquer the challenges and transcend itself in the ever-changing Chinese pharmaceutical environment. 2018 is a key year of strategic transformation for CMS. The Group is gradually developed into a well established, innovative-driven Specialty Parma, treating the development of the high quality innovative patent products as the core strategy to expand products blueprint and to fulfill the unmet medical needs in Chinese market. At present, the main innovative patent products are developed via the combination of self-research and collaborative research, covering the fields of nervous system, anti-tumor, cardio-cerebral vascular diseases and so on. While bringing the new therapeutic treatments and hopes to Chinese patients, each of these products has a huge market potential at the same time. For the future, with more innovative patent products continually inject fresh blood into the Group, which will bring a broader prospect for CMS. We are looking forward to witnessing the future development with global investors